{
    "2019-05-20": [
        [
            {
                "time": "",
                "original_text": "华熙生物遭到上交所问询：将他人专利计入自身无形资产是否合理 问询",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "上交所",
                        "问询",
                        "专利",
                        "无形资产"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "科创板明星生物医药企业巡礼系列(二):心脉医疗、华熙生物",
                "features": {
                    "keywords": [
                        "科创板",
                        "生物医药",
                        "明星企业",
                        "心脉医疗",
                        "华熙生物"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}